Trials / Conditions / Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
5 registered clinical trials studyying Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Dasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic NCT01256398 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Veliparib and Temozolomide in Treating Patients With Acute Leukemia NCT01139970 | National Cancer Institute (NCI) | Phase 1 |
| Active Not Recruiting | Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblas NCT00792948 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leu NCT00720109 | National Cancer Institute (NCI) | Phase 2 / Phase 3 |
| Completed | Fludarabine Phosphate and Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Tr NCT00036738 | Fred Hutchinson Cancer Center | Phase 2 |